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Specific Care Question
For the patient who will be undergoing a surgical procedure, does the dry time of the products used for skin disinfection impact the risk of surgical site
infection (SSI)?
Recommendations Based on Current Literature
No recommendation is can be made for or against optimal dry time of surgical site preparation agents, based on expert
review of current literature by the Department of EBP. The overall certainty in the evidence is very low d. Only one randomized controlled study (Yasuda
et al., 2015) was identified that compared surgical site preparation agents and there was no difference in site infections when comparing the group that
did not have a wait time, to the group that had an approximate 5 minute wait time. When there is a lack of scientific evidence, standard work should be
developed, implemented, and monitored (see Summary by Outcome for substantiation of this recommendation).
Literature Summary
Background. Skin antisepsis is the pre-operative treatment of intact skin in the operating room to reduce the microbial load on the patient’s skin prior
to making the surgical incision (WHO, 2018). Products used for skin antisepsis can be categorized as aqueous based or alcohol based (Armstrong,
Patrick, & Erstad, 2001). Aqueous products are iodophor formulations, while alcohol-based products are formulations of isopropyl alcohol combined with
iodophors or chlorhexidine (WHO, 2018). Alcohol based skin antiseptic agents are recommended for most surgeries (Berrios-Torres et al., 2017; WHO,
2018; AST, 2008), but these agents should not be used on mucous membranes (AST, 2008). Although alcohol-based products are valued for their
quicker drying time (Armstrong et al., 2001; Magalini et al., 2013), they have been implicated in operating room fires (Jones et al., 2017; Weber,
Hargunani, & Wax, 2006). This review will summarize identified literature on the topic.
Study characteristics. The search for suitable studies was completed on May 7, 2019. L. Harte, PharmD, CPHQ reviewed the seven titles and/or
abstracts found in the search and identified six articles believed to answer the question. After an in-depth review one article, an RCT, answered the
question (Yasuda et al., 2015). The Center for Disease Control (CDC) guidelines (Berrios-Torres et al. (2017) and the Association of Surgical
Technologists (AST, 2008) are the primary source of information for this analysis. Additionally, one case study (Weber et al., 2006) and one in vitro
study (Jones et al., 2017) were identified on risk of fire with solutions used for surgical preparation (prep).
Summary by Outcome
Infection. Yasuda et al. (2015) compared no wait time after application of povidone iodine (PVI) versus 5-minute wait time (approximate) after
application of PVI and measured the outcomes of Positive Cultures and SSI (N = 89). The odds of having a positive culture were significantly less in the
wait time group OR = 0.16, p = .008, 95% CI [0.04, 0.61]. For the outcome SSI, there was no difference in the number of SSI based on the wait time
versus no wait time. There is very low certainty in this finding. The risk of bias is unclear, as randomization was not clearly reported, nor was blinding of
subjects, personnel, or outcome assessors (see Figure 2). The evidence is indirect as only culture from the wound edge were reported, and a sample
size calculation was not reported to know if enough subjects were recruited into the study. Finally, since only one study is included in this review,
imprecision of the finding is serious (see Table 1).
Other. Although other trials were not identified that compared antiseptic dry time of various products with the outcome risk of SSI, the following points
can be made:
•
The CDC (Berrios-Torres et al., 2017) and the AST (AST, 2008) recommends that alcohol-based products be used for skin prophylaxis in
preparation for surgery. However alcohol-based products should not be used on mucous membranes, rather aqueous iodophor products, such
as PVI, are recommended for this surgery type (AST, 2008).
•
Dry times (in seconds) of alcohol-based products and iodophor products are significantly less than dry times of iodophor products (see Figure
3):
o ChlorPrep (alcohol based) vs. PVI (aquaeous based), MD = -53.0, 95% CI [-70.18, -35.82] (Magalini et al., 2013)
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o DuraPrep (alcohol based) vs. PVI,(aquaeous based), MD = -31.8, 95% CI [-57.82, -5.78] (Armstrong et al., 2001)
Weber et al. (2006) reported a case study of an operating room fire in a hirsute 62-year old male after surgical prep with DuraPrep. The
operative field was draped after the patient’s neck was shaved and the surgical prep solution was allowed to dry for at least 3 minutes. After
skin incision and retraction, the electrocautery device was activated, and a flameless, smokeless fire occurred. Recommendations from this
paper include:
o Avoid the use of DuraPrep in the hirsute patient, collection of the agent on hair bearing skin can slow the dry time
o The pooling of alcohol prep solution for any reason should be avoided
o Oxygen deliver during skin antisepsis should be a the minimal level to meet patient’s need
In an animal model, Jones et al. (2017) applied both alcohol (4% CHG with 70% isopropyl alcohol (IPA); plain IPA (70%); iodine-IPA, (0.7%
iodine povacrylex and 74% IPA) and nonalcohol-based (4% CHG or 1% PVI paint) skin preps to porcine skin samples. Electrocautery was
performed, with an electrosurgical pencil, immediately after application and after at least a 3-minute dry time.
o Nonalcohol-based skin preps did not cause a fire for either dry times.
o Alcohol-based skin preps did cause a fire in 22% (13/60) with no time allowed for prep to dry and 6% (10/60) where at least a 3minute dry time was allowed.
o Pooling of chlorhexidine-IPA created more fires
▪
No time for prep dry there were 10% (2/20) fires in the no pooling group and 19/20 (95%) in the pooling group, p < .001
▪
Time for prep to dry group there were 15% (3/20) fires in the no pooling group and 75 % (15/20) in the pooling group, p < .001

Identification of Studies
Search Strategy and Results (see Figure 1)
PubMed: surgical site infection AND skin preparation AND (dry OR timing)
Records identified through database searching n = 6
Additional records identified through other sources n = 7
Studies Included in this Review
Citation
Yasuda et al. (2015)

Study Type
RCT

Studies Not Included in this Review with Exclusion Rationale
Citation
Armstrong et al. (2001)
AST (2008)
Berrios-Torres et al. (2017)
Hemani and Lepor (2009)
Hibbard, Mulberry, and Brady (2002)
Hibbard (2005)
Johnson et al. (2016)
Jones et al. (2017)
Magalini et al. (2013)
Moen, Noone, and Kirson (2002)
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Sidhwa and Itani (2015)
Weber et al. (2006)
WHO (2018)

Does not address antiseptic drying time and SSI
Does not address antiseptic drying time and SSI
Does not address antiseptic drying time and SSI

Methods Used for Appraisal and Synthesis
aThe Appraisal of Guidelines Research and Evaluation II (AGREE II) is an international instrument used to assess the quality and reporting of clinical practice
guidelines for this analysis (Brouwers et al. 2010).
bRayyan is a web-based software used for the initial screening of titles and / or abstracts for this analysis (Ouzzani, Hammady, Fedorowicz & Elmagarmid,
2017).
cReview Manager (Higgins & Green, 2011) is a Cochrane Collaborative computer program used to assess the study characteristics as well as the risk of bias
and create the forest plots found in this analysis.
d The GRADEpro Guideline Development Tool (GDT) is the tool used to create the Summary of Findings table(s) for this analysis (see Table 1).
eThe Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram depicts the process in which literature is searched,
screened, and eligibility criteria is applied (Moher, Liberati, Tetzlaff, & Altman, 2009).
aBrouwers,

M.C. et al. for the AGREE Next Steps Consortium. (2010) AGREE II: Advancing guideline development, reporting and evaluation in
healthcare. Canadian Medical Association Journal, 182, E839-842. Retrieved from https://www.agreetrust.org/wp-content/uploads/2017/12/AGREEII-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf
bOuzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan-a web and mobile app for systematic reviews. Systematic Reviews, 5(1),
210. doi:10.1186/s13643-016-0384-4
cHiggins, J. P. T., & Green, S. e. (2011). Cochrane Handbook for Systematic Reviews of Interventions [updated March 2011] (Version 5.1.0 ed.): The
Cochrane Collaboration, 2011.
dGRADEpro GDT: GRADEpro Guideline Development Tool (2015). McMaster University, (developed by Evidence Prime, Inc.). [Software]. Available
from gradepro.org.
eMoher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA
Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 For more information, visit www.prisma-statement.org.
Question Originator
Lory Harte, PharmD, CPHQ
Medical Librarian Responsible for the Search Strategy
Keri Swaggart, MLIS, AHIP
EBP Scholar’s Responsible for Analyzing the Literature
Erin Lindhorst, MS, RD, LD
EBP Team Member Responsible for Reviewing, Synthesizing, and Developing this Document
Nancy Allen, MS, MLS, RD, LD, CPHQ
Acronyms Used in this Document
Acronym
Explanation
AST
Association of Surgical Technologists
CAT
Critically Appraised Topic
CDC
Centers for Disease Control
CHG
Chlorhexidine
CMH
Children’s Mercy Hospital
CPG
Clinical Practice Guideline
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EBP
IPA
MD
OR
PRISMA
Prep
PVI
RCT
SSI
WHO

Evidence Based Practice
Isopropyl Alcohol
Mean Difference
Odds Ratio
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
Preparation
Povidone Iodine
Randomized Controlled Trial
Surgical Site Infection
World Health Organization

Date Developed/Updated
July 2019
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRIMSA)e
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AGREE IIa Summary for the CDC Prevention of SSI Guideline (Berrios-Torres et al., 2017)
Domain

Percent Agreement

Scope and purpose

86%

Stakeholder involvement

81%

Rigor of development

81%

Clarity and presentation

93%

Applicability

46%

Editorial independence

94%

Overall guideline assessment

90%

Team’s recommendation for guideline use

Yes with modifications
Note: Four EBP Scholars completed the AGREE II on this guideline.
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Figure 2. Risk of Bias Summary
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Table 1

Summary of Findings Table: Wait Time vs. No Wait Time for Surgical Site Preparation Solution
Certainty assessment

№ of
participants
(studies)
Follow-up

Risk
of
bias

Summary of findings

Study event rates
(%)
Overall
Publication certainty
Inconsistency Indirectness Imprecision
With no
With
bias
of
wait
Wait
evidence
time
time

Relative
effect
(95% CI)

Anticipated absolute
effects
Risk
with no
wait
time

Risk
difference
with Wait
time

302 per
1,000

237 fewer
per 1,000
(from 285
fewer to 93
fewer)

0 per
1,000

0 fewer per
1,000
(from 0 fewer
to 0 fewer)

Positive Cultures
89
(1 RCT)

serious
a

not serious

serious

b

serious

c

none

⨁◯◯◯
VERY LOW

13/43
(30.2%)

3/46
(6.5%)

0/43
(0.0%)

2/46
(4.3%)

OR 0.16
(0.04 to 0.61)

SSI Infection
89
(1 study)

serious
a

not serious

serious

b

serious

c

none

-

OR 4.89
(0.23 to
104.76)

Notes:
a. Reporting on randomization; allocation concealment; blinding of participant, personnel, and outcome assessors is poorly reported;
b. Cultures were only collected from the wound edge;
c. It is a single study with 89 subjects.
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Figure 3. Comparison of PVI alcohol mixture vs. PVI/iodophor, Outcome: Dry time
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Characteristics of Studies
Armstrong 2001
Methods
Participants

Interventions

Clinical Trail (not randomized)
Participants:
• Twenty-five operating room personnel
• Twenty-five subjects (patient volunteers)
Setting: College of Pharmacy, Arizona, US
Participated in study: N = 50
• Group 1, Operating room personnel*: n = 25
o Povidone iodine paint and scrub (7.5% povidone iodine, 10% water, Operand; APlicare, Inc., Branford CT
o Duraprep (0.7% iodophor, 74% isopropyl alcohol; 3M Health Care plus Ioban in combination
o Prevail (5% povidone iodine, 62% alcohol; Allegiance Health care Corp., McGaw Park, IL
o LiquiDrape not FDA approved at time of the study, Tradmark for this product has been abandoned
https://trademark.trademarkia.com/liquidrape-75404162.html July 2 2019
• Group 2, Patient volunteers: n = 25
Completed Study: N = 50
• Group 1, Applied surgical prep*: n = 25
• Group 2, Had surgical prep applied: n = 25
Gender, males (as defined by researchers):
• Not reported
Race / ethnicity or nationality (as defined by researchers):
•
Not reported
Age:
• Not reported
Inclusion Criteria:
• Both groups - greater than or equal to 18 years of age
• Both groups - free of known hypersensitivity to povidone iodine or alcohol
• Operating room personnel - at least six months experience assisting in pre-operative patient preparation
Exclusion Criteria:
• Patient volunteer - rash, open sores, or pre-existing skin conditions on the lower extremities

•

•
•

Operating room personnel applied the four skin prep formulations to the lower extremity of the patient volunteers.
There were two rounds of application. The first round, two products were applied, one to each leg from the knee to
the ankle. The product was allowed to dry and then removed. The process was repeated with the remaining skin prep
products for the second round.
Patients were not required to shave their legs
Operating room personnel read the product insert instructions prior to application.
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Outcomes

Primary outcome(s):
• Product application
• Drying time
• Removal time
• Overall satisfaction

Magalini 2013
Methods
Participants

Interventions

Outcomes

Observational study
Participants: Surgeons performing elective and emergency surgeries (medium and major operations).
Setting: Hospital, Italy
Number enrolled into study: N = 100
• Group 1, Povidone iodine (PVI): n = 50
• Group 2, ChloraPrep: n = 50
Number completed: N = 100
• Group 1: n = 50
• Group 2: n = 50
Gender, males: Not reported
Race / ethnicity or nationality (as defined by researchers):
• Not reported
Age: Not reported
Inclusion criteria:
• Surgeon approval for observation
• Use of either PVI or ChloraPrep
Exclusion criteria:
• None listed
Covariates identified: not reported
Both: Every surgeon (27 unique surgeons were observed) performed their own surgical field and uses the two different
approaches defined below they start from the middle of the surgical field and swabbing out. When the field is almost dry they
may use a paper towel to complete the drying. All surgeons identified that they had received product training.
• Group 1: PVI is poured on the skin and gauze/clamp used
• Group 2: ChloraPrep applicator
Primary outcome(s):
• Comparison of IPV and ChloraPrep in supplies used
• Comparison of IPV and ChloraPrep in time for application, drying*, and total time needed for disinfection (defined as
from the beginning of painting to placing of drapes)
Secondary outcome(s)
• Surgeons opinion from the questionnaire
*Outcomes of interest to the CMH CPG or CAT development team
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Yasuda 2014

Methods
Participants

Interventions

Prospective, Randomized, controlled study
Setting: Department of Orthopaedic Surgery, Hamamatsu University of Medicine
Randomized into study: N = 89
• Group 1: No wait time for povidone-iodine applied, n = 43
• Group 2: Wait time povidone-iodine applied, n = 46
Completed study: N = 89
• Group 1: n = 43
• Group 2: n = 46
Gender, males:
• Group 1: n = 21
• Group 2: n = 23
Race / ethnicity or nationality (as defined by researchers):
• Not reported
Age, years (mean):
• Group 1: 61.9
• Group 2: 58.1
Inclusion criteria:
• Patients scheduled for spinal surgery
Exclusion criteria:
• Not reported
Power Analysis:
• Not reported
Both:

•

In all cases, the surgical field was sealed with an antimicrobial plastic adhesive wound drape just before starting the
surgery.
• Culture samples were collected by rubbing a cotton swab at the wound edge just before wound closure and then they
were incubated at 37-degree Celsius for 5 to 7 days.
• Cefazolin was administered three times on the day of surgery, before surgery, one hour after surgery, and six hours
after surgery, and two times on the next day as a prophylactic antibiotic.
Group 1: povidone-iodine was applied to the surgical site just before skin incision, after the surgeon’s hands were scrubbed.
Group 2: povidone-iodine was applied before the surgeon’s hands were scrubbed. Expected Wait time 5 minutes.
Outcomes

Results

Primary outcome:
• Culture results
Secondary outcome:
• SSI infection

•

In Group 1, coagulase negative Staphylococcus aureus was identified in one culture. In Group 2, three different
bacteria (streptococcus, staphylococcus epidermidis, and coagulase negative staphylococcus) were identified in the
culture.
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•
•
•

Two cases of SSI (deep infection) (2 out of 46 patients, 4.3%) were identified in group 2 four weeks after surgery,
and cultures from the wound edge intraoperatively were negative. There was no case of SSI in Group 1 after the
surgery.
Because bacteria on the skin appeared significantly reduced by allowing povidone-iodine to dry for several minutes
prior to surgery, the researchers recommend this approach to reduce the incidence of postoperative infections. The
recommended drying time prior to surgery is 10 minutes.
A limitation of this study is that only analysis of cultures from the wound edge was conducted.

Risk of bias table
Bias

Scholars'
judgment

Random sequence generation
(selection bias)

Unclear risk

Allocation concealment
(selection bias)

Unclear risk

Blinding of participants and
personnel (performance bias)

Unclear risk

Blinding of outcome
assessment (detection bias)

Unclear risk

Incomplete outcome data
(attrition bias)

Unclear risk

Selective reporting (reporting
bias)

Unclear risk

Other bias

Low risk

Support for judgment
Patients were randomly allocated into 2 groups, however how they were randomized was not indicated.
Insufficient information to determine
The study did not address this outcome
Insufficient information to determine
All patients enrolled were analyzed. Although, no power analysis performed
SSI infections not tested for significance
The study appears to be free of other sources of bias.
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